Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

178 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Small renal oncocytomas: differentiation with multiphase CT.
Gakis G, Kramer U, Schilling D, Kruck S, Stenzl A, Schlemmer HP. Gakis G, et al. Eur J Radiol. 2011 Nov;80(2):274-8. doi: 10.1016/j.ejrad.2010.06.049. Epub 2010 Jul 27. Eur J Radiol. 2011. PMID: 20667676
An update on the medical therapy of advanced metastatic renal cell carcinoma.
Kruck S, Merseburger AS, Gakis G, Kramer MW, Stenzl A, Kuczyk MA. Kruck S, et al. Scand J Urol Nephrol. 2008;42(6):501-6. doi: 10.1080/00365590802203983. Scand J Urol Nephrol. 2008. PMID: 18615363 Review.
Novel therapeutic options in metastatic renal cancer - review and post ASCO 2007 update.
Kruck S, Kuczyk MA, Gakis G, Kramer MW, Stenzl A, Merseburger AS. Kruck S, et al. Rev Recent Clin Trials. 2008 Sep;3(3):212-6. doi: 10.2174/157488708785700311. Rev Recent Clin Trials. 2008. PMID: 18782079 Review.
The learning curve in minimally invasive percutaneous nephrolitholapaxy: a 1-year retrospective evaluation of a novice and an expert.
Schilling D, Gakis G, Walcher U, Stenzl A, Nagele U. Schilling D, et al. World J Urol. 2011 Dec;29(6):749-53. doi: 10.1007/s00345-010-0553-3. Epub 2010 Apr 18. World J Urol. 2011. PMID: 20401661
Sequential resection of malignant ureteral margins at radical cystectomy: a critical assessment of the value of frozen section analysis.
Gakis G, Schilling D, Perner S, Schwentner C, Sievert KD, Stenzl A. Gakis G, et al. World J Urol. 2011 Aug;29(4):451-6. doi: 10.1007/s00345-010-0581-z. Epub 2010 Jul 9. World J Urol. 2011. PMID: 20617438
XPA-210: a new proliferation marker to characterize tumor biology and progression of renal cell carcinoma.
Gakis G, Hennenlotter J, Scharpf M, Hevler J, Schilling D, Kuehs U, Stenzl A, Schwentner C. Gakis G, et al. World J Urol. 2011 Dec;29(6):801-6. doi: 10.1007/s00345-010-0621-8. Epub 2010 Nov 27. World J Urol. 2011. PMID: 21113600
Comparison of the new American Joint Committee on Cancer substratification in node-negative pT2 urothelial carcinoma of the bladder: analysis of patient outcomes in a contemporary series.
Gakis G, Schilling D, Renninger M, Seibold J, Sievert KD, Stenzl A. Gakis G, et al. BJU Int. 2011 Mar;107(6):919-23. doi: 10.1111/j.1464-410X.2010.09548.x. Epub 2010 Sep 7. BJU Int. 2011. PMID: 21392208
Exposed proliferation antigen 210 (XPA-210) in renal cell carcinoma (RCC) and oncocytoma: clinical utility and biological implications.
Kruck S, Hennenlotter J, Vogel U, Schilling D, Gakis G, Hevler J, Kuehs U, Stenzl A, Schwentner C. Kruck S, et al. BJU Int. 2012 Feb;109(4):634-8. doi: 10.1111/j.1464-410X.2011.10392.x. Epub 2011 Jun 28. BJU Int. 2012. PMID: 21711439
. •  RCC XPA-210 staining was significantly associated with higher tumour stage (T = 3, P = 0.002) and grade (G = 3, P = 0.001). ...
. •  RCC XPA-210 staining was significantly associated with higher tumour stage (T = 3, P = 0.002) and grade (G = 3, P = 0.001). ...
178 results
Jump to page
Feedback